Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever

Ki vehet részt

• I1. ≥ 18 years of age
• I2. Clinical signs and symptoms of low-risk Intermediate pulmonary embolism defined per 2019 ESC Guidelines:
• Only one of the following:
• Presence of either RV strain or RV dilation on CT scan or Echo TTE
• 4th generation Troponin T > 0.01 ng/mL or 5th generation Troponin T >14 ng/L; Troponin I > 51.4 ng/L (Northwell reference laboratory); I3. sPESI score 0 or >1*; *Signs of RV dysfunction on Echo TTE or CTPA or elevated cardiac biomarker levels may be present, despite a calculation of sPESI 0; I4. Echocardiogram, Computed Tomography Pulmonary Angiogram, or pulmonary angiographic evidence of proximal filing defect in at least one main, lobar, or segmental pulmonary artery with or without pulmonary infarction; I5. Hemodynamically stable

Ki nem vehet részt

• E3. Known sensitivity to radiographic contrast agents that cannot be pre-treated
• E1. Patients with active and severe COVID-19 infection (e.g. using ventilator, requiring hemodynamic support)
• E2. Unable to anti-coagulate with heparin or alternative
• E4. Life expectancy < 6 months
• E5. Current participation in another study that may interfere with the patient's participation in this study
• E6. Inability to consent
• E7. Patient is pregnant or plans to become pregnant within the next 6 months and/or currently breastfeeding
• E8. Subsegmental pulmonary embolism only